Rosiglitazone treatment increases plasma levels of adiponectin and decreases levels of resistin in overweight women with PCOS: a randomized placebo-controlled study (Q79743330)
Jump to navigation
Jump to search
scientific article published on 01 February 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rosiglitazone treatment increases plasma levels of adiponectin and decreases levels of resistin in overweight women with PCOS: a randomized placebo-controlled study |
scientific article published on 01 February 2007 |
Statements
Rosiglitazone treatment increases plasma levels of adiponectin and decreases levels of resistin in overweight women with PCOS: a randomized placebo-controlled study (English)
A Majuri
M Santaniemi
K Rautio
A Kunnari
J Vartiainen
A Ruokonen
Y A Kesäniemi
J S Tapanainen
O Ukkola
L Morin-Papunen
1 February 2007